6 European Projects Found
Searched on 125080 European Projects
FINISHED
Accelerated Development of Vaccine benefit-risk Collaboration in Europe (ADVANCE)
Start date: Oct 1, 2013, End date: Sep 30, 2018,
Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to rapidly provide robust data on vaccine benefits and risks to support accelerated decision-making.Approach: To achieve this vision through a public-private partnership, ADVANCE partners 1. establish common grounds and rules for collaboration between public and ...
Read Project
30
Partners Participants
FINISHED
Nanotherapeutics for antibiotic resistant emerging bacterial pathogens (NAREB)
Start date: Feb 1, 2014, End date: Jan 31, 2018,
Increase in antibiotic resistance is a global concern worldwide. The project NAREB's main objective is the optimization of several nanoformulations of antibacterial therapeutics in order to improve the therapy of multi-drug resistant (MDR) tuberculosis (TB) and MRSA infections in European MDR patients.NAREB will address the problem of drug bioavailability inside the infected macrophages, transport ...
Read Project
16
Partners Participants
FINISHED
European Research Infrastructures for Poverty Related Diseases (EURIPRED)
Start date: Nov 1, 2013, End date: Oct 31, 2017,
HIV/AIDS, Tuberculosis (TB) and Malaria alone account for more than six million deaths worldwide every year. Despite substantial efforts made in recent years, Poverty Related Diseases are still spreading. New therapeutic interventions are therefore urgently required to combat Poverty Related Diseases. The existence of a well-developed HIV/TB/Malaria infrastructure presents a prime opportunity to a ...
Read Project
18
Partners Participants
FINISHED
Universal Influenza Vaccines Secured (UNISEC)
Start date: Oct 1, 2013, End date: Sep 30, 2017,
UNISEC brings together a European consortium of 3 University partners, 5 National Health Institutes and 3 SMEs, all with leading expertise in influenza vaccine research and development, to work on promising recently developed concepts for a universal influenza vaccine. The consortium is exceptionally strong, interdisciplinary and intersectional in nature, and encompasses a unique combination of sc ...
Read Project
15
Partners Participants
FINISHED
"Neutralizing antibodies against botulinum toxins A,B,E" (ANTIBOTABE)
Start date: Sep 1, 2010, End date: Feb 28, 2015,
"Botulinum neurotoxins (BoNTs), the most toxic substances known, are susceptible for use as bioweapons (listed as class A agents by CDC). Currently licensed animal derived antibodies or F(ab’)2 preparations, are at a high risk of inducing adverse effects and their privately-owned stockpiles are limited. In this project, we will target the most lethal types of BoNTs: A (subtypes A1 and A2), B (B1 a ...
Read Project
11
Partners Participants
FINISHED
Pharmaceutical Medicine Training Programme (PHARMATRAIN)
Start date: May 1, 2009, End date: Apr 30, 2014,
...red towards greatly enhancing the skillsetsand competencies of all key contributors to the drug development and regulatory processes using the latestscientific approaches to base the development of medicines on pathophysiology, safety and risk-awareness patient and population-based benefit as well as to make the process faster, more economical and more competitive with other parts of the world tha ...
Read Project
